Resch, I., Shariat, S. F., & Gust, K. M. (2018). PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients: Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer. Memo.
Chicago Style CitationResch, Irene, Shahrokh F. Shariat, i Kilian M. Gust. "PD-1 and PD-L1 Inhibitors After Platinum-based Chemotherapy or in First-line Therapy in Cisplatin-ineligible Patients: Dramatic Improvement of Prognosis and Overall Survival After Decades of Hopelessness in Patients With Metastatic Urothelial Cancer." Memo 2018.
Cita MLAResch, Irene, Shahrokh F. Shariat, i Kilian M. Gust. "PD-1 and PD-L1 Inhibitors After Platinum-based Chemotherapy or in First-line Therapy in Cisplatin-ineligible Patients: Dramatic Improvement of Prognosis and Overall Survival After Decades of Hopelessness in Patients With Metastatic Urothelial Cancer." Memo 2018.